Roche Diagnostics GmbH (manufacturing of medicinal product (including filling/primary packaging), in-process control testing, quality control testing, release of unpackaged product, stability testing, storage of medicinal product)

The drug is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with signs of active disease, as well as for the treatment of adults with early primary progressive multiple sclerosis (PPMS).

Dosage form: solution for injection

ATC: L04AG08